Physician profile
Stephen Mark Langley
NPI 1356531347
$3,349.93
in general payments reported to CMS, 2019-2025
17 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.49 · 2020: $368 · 2021: $2,145 · 2022: $349 · 2024: $121 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Theater. INC. | $1,624.34 | 2021 | |
| Edwards Lifesciences Corporation | $282.23 | 2020-2021 | |
| Phadia US INC. | $165.08 | 2021-2022 | |
| Mirum Pharmaceuticals, INC. | $149.91 | 2025 | Livmarli |
| Abbott Laboratories | $137.89 | 2022 | |
| Getinge USA Sales, LLC | $122.59 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $121.52 | 2025 | Koselugo |
| Pharming Healthcare, INC. | $121.38 | 2024 | Joenja |
| Regeneron Healthcare Solutions, INC. | $119.24 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $111.65 | 2021 | |
| Novartis Pharmaceuticals Corporation | $89.78 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $85.01 | 2022 | |
| Genentech, INC. | $72.89 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.21 | 2022 | |
| Elutia, INC. | $43.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $30.09 | 2019 | |
| Medinc of Texas | $21.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Langley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.